Schedule and Publications

The final schedule for the 2024 Scientific Sessions will be announced in October 2023, coinciding with the launch of the Online Planner. The first publication, the Primary Program PDF, will follow in December 2023. In the meantime, this web page contains the list of accepted Continuing Education courses and tentatively accepted Scientific Sessions.

Courses and Sessions

ABBREVIATION KEY: Innovations in Applied Toxicology (IAT)| Innovations in Toxicological Sciences (ITS)

Sunday, March 10

Continuing Education Courses

separate registration and extra fee required

The SOT Continuing Education Committee has accepted 13 courses for presentation during the 2024 SOT Annual Meeting and ToxExpo. For more details, visit the “Continuing Education” web page.

Sunrise Course

  • Plastic Chemical Additives: Determining Human Risk from Microplastic Exposure

Morning Courses

  • Advances in Metal Toxicology: From Aging and Disease Causation to Detection and Regulatory Measures
  • Foundations of Embryonic and Fetal Development and Application to Developmental Toxicity Testing
  • High-Throughput In Vitro–In Vivo Extrapolation for Predictive Toxicology
  • Nix the Six: Strategies for Implementing Nonanimal Acute Toxicity Testing
  • “Relax, Immune System,” Cell and Gene Therapy Here
  • Weight of Evidence Analysis and Problem Formulation for Chemical Risk Assessment: Fundamental Principles and Application through Case Example

Afternoon Courses

  • Benchmark Dose Modeling and Its Applications in Drug, Food, and Chemical Safety Evaluation and Assessment
  • Bridge over Adverse Waters: Integrating Pathology Findings into the Interpretation of Toxicology Studies
  • Harnessing Toxicology in Pregnancy: Traditional and Novel Approaches to Placental Toxicology Research
  • Next-Generation Data Transparency and Open Science Policies: What Toxicologists Need to Know
  • Putting Theory into Practice: Using Computational New Approach Methodologies in Next-Generation Risk Assessment
  • Use of New Approach Methodologies for the Assessment of Inhaled Substances: Examples and Case Studies
Tentatively Accepted Sessions

Symposium Sessions

90- and 165-minute sessions

  • Accelerating Discovery in Parkinson’s Disease: A Blueprint for Modeling Environmentally Relevant Exposures through Cross-Disciplinary Collaboration
  • Advances in New Approach Methods for Thyroid Toxicity Testing
  • Botanical-Induced Toxicity: Liver Injury and Botanical Drug Interactions
  • Burn Pit and Wildfire Aerosols—Chemical Composition and Health Consequences: What Is in Common?
  • Capturing Unknowns: Increasing Utility of Epidemiologic Studies as Key Evidence in Chemical Risk Assessment
  • Current Status, Challenges, and Future Considerations: Advancing NAMs for Assessing Inhalation Toxicity
  • Defining Susceptibility to Ozone: A Window into Exposure Effects in a Changing Climate
  • Error-Corrected Next-Generation Sequencing Strategies for Direct Assessment of Mutagenesis and Early Identification of Cancer Risk (IAT)
  • Evaluation of Human Health Safety of Cosmetics and Personal Care Products in Minority and Sensitive Populations
  • Exploring Drug-Induced Vascular Injury: Emerging Mechanisms, Biomarkers, Novel Approaches, and Regulatory Insight (IAT)
  • Harmful Algal Blooms and Human Health
  • In Vitro to In Vivo Extrapolation to Predict Developmental Toxicity Potential
  • It Takes Two! Paternal Exposures and Their Impacts on Offspring Health (ITS)
  • Long Non-coding RNA Dysregulations in Metal Toxicity and Carcinogenesis
  • Looking through the Haze: Is the Picture Any Clearer on the Effects of Cannabis and Cannabis-Related Products on Reproduction and Development?
  • Mechanisms of Per- and Polyfluorinated Substances Action: PPARα and Beyond
  • Multi-’omics Approaches to Unravel PFAS-Mediated Metabolic Dysfunction
  • Neuroinflammation as a Central Mediator of Neurotoxicity: Implications for Environmental Links to Chronic Neurodegenerative Diseases
  • New Approach Methodology (NAM) and Kinetic Modeling Approaches to Support Read-Across
  • Nitrosamines: Mechanistic Evidence to Support Subclasses with Varying Mutagenic Potency
  • Practical Applications of Machine Learning for Gaining Mechanistic Insights in Toxicology
  • Preclinical Development of RNA-Editing, Gene, and Cell Therapies: Risks and Challenges
  • Qualification of Complex In Vitro Models as Drug Development Tools: How Do We Translate Exciting Science into Regulatory Decisions? (ITS)
  • State-of-the-Art In Vitro Immune Modeling: The Beginning of a Journey toward AOPs and Improved Safety Assessment
  • Take a Deep Breath: Opportunities and Challenges in Toxicology Studies for Inhaled Drug Development
  • Taking a Closer Look at Biological Evaluations for Ocular Medical Devices and Combination Products
  • The “Cocktail Effect”: Studying the Greatest Uncontrolled Experiment Ever Launched!
  • The Lifesaver or the Devil? Identify Key Molecular Signaling Pathways and Their Roles in Chronic Exposure-Induced Neurological Diseases
  • The State of the Science Linking Environmental Chemicals to Age-Related Neurocognitive Disease
  • The Ties That Bind: Evaluating the Impact of PFAS Protein Binding and Transport on Persistence and Tissue Distribution
  • Thyroid System–Disrupting Chemicals and the Developing Brain
  • Translational Approaches to Study Transporters in Toxicology: From Liquid Biopsies and Endogenous Biomarkers to Machine Learning and Epidemiology
Tentatively Accepted Sessions

Workshop Sessions

90- and 165-minute sessions

  • Addressing Health Inequities and Susceptibilities via Incorporation of Non-chemical Stressors within Toxicological Approaches and Cumulative Risk Assessments
  • Advancements in Utilizing Zebrafish-Based Behavioral Assays for Detecting Developmental Neurotoxicity and Understanding Associated Cellular and Molecular Changes
  • Allergies Are More Than Skin Deep: Establishing Regulatory Test Methods for Respiratory Sensitization
  • Application of Early Molecular Measurements to Develop Points of Departure for Risk Assessment
  • Applications of Annotations and Ontologies in Toxicology to Get Us on the Same Page for Maximizing Data Potential
  • Cardiac Arrhythmias in Toxicology: Getting to the Heart of the Matter
  • Challenges and Future Perspectives on New Approach Methodologies for Developmental Immunotoxicity Testing
  • Complex Interpretations of Substance Detection and Impairment (IAT)
  • Integrating Aggregate Exposure Pathways and Adverse Outcome Pathways for Comprehensive Risk Assessment of Chemical Mixtures
  • Into the Unknown: Unique Aspects of Evaluating Potential Reproductive and Developmental Toxicity of New Pharmaceutical Modalities
  • It’s Not Easy Being Green: Applying Alternatives Assessment to Create Safer Consumer Products
  • Making Sense of Chaos: Recent Advances in Complex Mixtures Research and Regulation
  • Next-Generation Risk Assessment Calls for an Evidence-Based Next-Generation Uncertainty Assessment
  • On the Edge of the NAMs Frontier: Pioneering Efforts toward Intra- and Internationally Harmonized Regulatory Applications of New Approach Methodologies
  • Overcoming Barriers to More Scalable Environmental Health Science Research via Harmonized Language
  • Overcoming Unique Challenges Associated with Biological Evaluation of Absorbable/Degradable Medical Devices and Combination Products: Regulatory and Scientific Considerations from Successful Case Studies
  • Reducing Use of Nonhuman Primates in Oncology Drug Development: A 3R-Based IQ DruSafe/Industry/FDA Perspective
  • Revolutionizing Detection and Prevention of Neurotoxic Effects: Harnessing the Power of In Vitro and In Silico Approaches for Safer Drug Development and Environmental Monitoring
  • Update on the Development of Medical Countermeasures and Biomarkers against Pulmonary Chemical Threat Agents
  • Use of PBPK and Novel Pharmacokinetic Approaches for the Quantitative Prediction of Tissue Residue and Withdrawal Times for Human Food Safety Assessment
  • Using Geographical Information to Promote Environmental Health and Justice
Tentatively Accepted Sessions

Roundtable Sessions

80-minute sessions

  • Current Status of Diversity, Equity, Inclusion, and Accessibility in Toxicology: SOT Special Interest Groups as Models
  • From Theory to Practice: Preparing Students for Careers in 21st-Century Toxicology
  • Is Less More? Reduction of Animal Use through Virtual Control Groups
  • Women’s Health on the Frontlines: Science behind Sex-Specific Toxicology Differentials, Health Disparity, and Marginalization and Their Ethical Implications (IAT)
Tentatively Accepted Sessions

Informational Sessions

80-minute and 165-minute sessions

  • Five Decades of Evaluating the Safety of Aspartame Consumption: Has Anything Changed?
  • From My Cosmetics to Smart Watch, Toxicology Touches It All!
  • Methods and Transdisciplinary Frameworks to Evaluate Cumulative Impacts to Advance Equity in Community Health, Well-Being, and Quality of Life
  • Risk Communication of PFAS: Challenges and Opportunities
  • The Modernization of the Cosmetic Regulation Act: Perspectives on Recent Implementation Activities and Confirming Safety in Cosmetic Products
  • Through the Lens: Translational Insights in Ocular Toxicology
Tentatively Accepted Session

Historical Highlights Session

80-minute session

  • Take Heart: Learning from Our Past to Improve Cardiovascular Safety Assessments of Pharmaceuticals in the Future
Tentatively Accepted Sessions

Education-Career Development Sessions

80-minute sessions

  • Decoding the Role of a Project Toxicologist in the (Bio)pharmaceutical Industry
  • Empowering Career Growth through Effective Mentoring and Networking for Toxicologists
  • Navigating Career Transitions and Acclimation: The Art of a Scientific Career (ITS)
  • Preparing the Next Generation of Toxicologists: Integrating Practical Applications and Diverse Career Paths into the Student Experience
  • Toxicology in the Military: Unique Career Opportunities and Applications